Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.
about
Population genetic tools for dissecting innate immunity in humansToll-like receptors (TLRs) and mannan-binding lectin (MBL): on constant alert in a hostile environment.Mannose-binding lectin and maladies of the bowel and liverAssociation of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: a family studyMannose binding lectin genotypes influence recovery from hepatitis B virus infectionHuman serum mannose-binding lectin senses wall teichoic acid Glycopolymer of Staphylococcus aureus, which is restricted in infancy.Genetic evidence of functional ficolin-2 haplotype as susceptibility factor in cutaneous leishmaniasisMannose-binding lectin in innate immunity: past, present and future.Intradermal immunization with wall teichoic acid (WTA) elicits and augments an anti-WTA IgG response that protects mice from methicillin-resistant Staphylococcus aureus infection independent of mannose-binding lectin statusThe lectin pathway of complement and rheumatic heart disease.Role of mannose-binding lectin deficiency in HIV-1 and schistosoma infections in a rural adult population in Zimbabwe.Association of Ficolin-2 Serum Levels and FCN2 Genetic Variants with Indian Visceral Leishmaniasis.Genetically Determined MBL Deficiency Is Associated with Protection against Chronic Cardiomyopathy in Chagas Disease.Blood Transcriptional Profiling Reveals Immunological Signatures of Distinct States of Infection of Humans with Leishmania infantum.The role of the mannose-binding lectin in innate immunity.Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome.Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice.Mannose-Binding Lectin: Biologic Characteristics and Role in the Susceptibility to Infections and Ischemia-Reperfusion Related Injury in Critically Ill Neonates.Mannose-binding lectin alleles in sub-Saharan Africans and relation with susceptibility to infections.The interaction of mannose binding lectin (MBL) with mannose containing glycopeptides and the resultant potential impact on invasive fungal infection.Mannose-binding lectin and susceptibility to schistosomiasis.Association of a new mannose-binding lectin variant with severe malaria in Gabonese children.Functional variations in MBL2 gene are associated with cutaneous leishmaniasis in the Amazonas state of Brazil.Evasion Mechanisms Used by Pathogens to Escape the Lectin Complement PathwayMannan-binding lectin and RSV lower respiratory tract infection leading to hospitalization in children: a case-control study from Soweto, South Africa.Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes.Mannose-Binding Lectin Levels Could Predict Prognosis in IgA Nephropathy.Migration of Fasciola hepatica newly excysted juveniles is inhibited by high-mannose and oligomannose-type N-glycan-binding lectins.Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation.Complement interaction with trypanosomatid promastigotes in normal human serum.Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles.Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism.The role of complement in the early phase of Leishmania (Leishmania) amazonensis infection in BALB/c mice.Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy.Role of the mannose-binding lectin in innate immunity.Mannose-binding lectin deficiency alters the development of fungal asthma: effects on airway response, inflammation, and cytokine profile.Serum levels and H/L gene polymorphism of mannose-binding lectin in primary open angle glaucoma.The emerging role of complement lectin pathway in trypanosomatids: molecular bases in activation, genetic deficiencies, susceptibility to infection, and complement system-based therapeutics.Low Mannan-Binding Lectin Serum Levels Are Associated With Complicated Crohn's Disease and Reactivity to Oligomannan (ASCA)
P2860
Q27001032-74E58FDB-EE5E-47A6-AB7B-BA1B8A5B514DQ27692121-FBACFEAF-896D-4084-9FA1-F00BE15FAA00Q28271075-D4508523-62C4-47A1-88D4-1F4C4795D1CFQ28300602-6945C6F8-49DC-47F8-A299-E69128092A05Q33883928-D3BF228C-9AE6-46B3-9EF5-63DDC86B3542Q34094512-39818128-8CCC-4E76-9383-C16256AB15CDQ34212182-E73C352F-C9DD-4C8E-98C7-15657EAC23DDQ34562723-F6A65223-8341-4619-8312-8A7E029ACA64Q34924567-38440AB6-9B1B-4BC0-B0F2-1C9A6A1B2238Q34991781-F037D661-E530-41BB-8921-FF6C0A60767BQ35241916-31F36BED-768B-4554-8697-64795B593F3AQ35597658-8FD2275D-85DD-44CD-A195-228AC1063C91Q35888603-E2A39F7F-64E2-445E-AD2F-9808B316EB69Q36187247-59BC5ED8-A947-43E9-9E3F-CB23EFAC251CQ36291716-FCDEF1B8-F5FF-434E-9E8F-6E3DE18F65C5Q36446944-BFD9EBF8-D3B9-4344-A0D9-3B9F17F94AD0Q36845171-DD95C62F-6ABD-455B-893C-2E4DE8A8A210Q37633125-EDA45814-404F-4735-99A0-2FB5033749B7Q38352781-40C4F1EB-C646-4EBF-B410-B9D136BDA332Q38356990-B45500E1-A60C-4B12-8EFF-A6F4E7513694Q38877044-BA6525B8-CEBB-4445-B445-C6BB2A9E0687Q38913656-02946E50-D8F9-410E-847D-AF77663AD3EEQ38964589-51A49C5E-E36E-4118-BF4E-F62169B6B260Q39335628-6F9ADE67-5BF5-4C26-B195-247EE5825A92Q39689167-A9D89C0C-B47B-4577-80A7-A82B816765C5Q39863819-1536457D-0227-4ABF-B37C-A524ADFED5E9Q40139078-0538F814-14BF-47C7-BFA6-4023B4222162Q40141979-03A23494-E907-40FA-B3EB-F53A26C56EE9Q41622831-D727CA22-E506-4DD9-84C4-C3C80F39E1EAQ41847949-6E9BEBD5-5C74-425F-BFD4-4E4BDA68AFA5Q44096290-7E9383CD-0C0B-4D1A-80C6-C4AABCA8E8B8Q46692780-9EE6E53C-83F4-4C8C-9530-39A1927EFCB3Q47831266-A7CC2F67-A08D-44EF-8069-1848F144FE89Q50568997-D55C506C-DCFF-4FB5-BDDE-53E0A7618867Q52104450-F133C151-5052-425D-9AA2-65D2372B5C69Q53904254-A1B29657-C8D5-4CB1-A691-8EB8D5262225Q54324076-9BD38C70-BBFE-4D76-8143-63D8A574EF5BQ55686634-AA848140-C9CA-45F3-9AB7-05E53E98D389Q58806614-78F27D34-E972-40E0-B81D-EEBD91CAD72F
P2860
Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.
@ast
Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.
@en
Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.
@nl
type
label
Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.
@ast
Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.
@en
Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.
@nl
prefLabel
Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.
@ast
Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.
@en
Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.
@nl
P2093
P2860
P1476
Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.
@en
P2093
D L Weiner
D Zurakowski
I K Santos
J E Epstein
M F Feitosa
R A Ezekowitz
P2860
P304
P356
10.1128/IAI.69.8.5212-5215.2001
P407
P577
2001-08-01T00:00:00Z